2017
DOI: 10.1016/j.cca.2017.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Association of serum asymmetric dimethylarginine, homocysteine, and l-arginine concentrations during early pregnancy with hypertensive disorders of pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 30 publications
2
3
0
Order By: Relevance
“…As in our previous report, ADMA-treated embryonic kidneys (metanephroi) results in dose-dependent decreases of nephron number [32]. Increased plasma ADMA levels are associated with adverse pregnancy and fetal outcomes such as preeclampsia [41], gestational diabetes [42], hypertension [43], IUGR [44], and prematurity [45].…”
Section: Oxidative Stress In Fetal Programmingsupporting
confidence: 53%
“…As in our previous report, ADMA-treated embryonic kidneys (metanephroi) results in dose-dependent decreases of nephron number [32]. Increased plasma ADMA levels are associated with adverse pregnancy and fetal outcomes such as preeclampsia [41], gestational diabetes [42], hypertension [43], IUGR [44], and prematurity [45].…”
Section: Oxidative Stress In Fetal Programmingsupporting
confidence: 53%
“…It is discovered that the immune system plays an important role in the occurrence and development of PIH. Immune cells play an important role in the pathogenesis of PIH by synthesizing and secreting cytokines [20,21]. In the present study, we demonstrated that the ratio and activity of NKT cells in peripheral blood and placental tissues from PIH patients was elevated.…”
Section: Resultssupporting
confidence: 59%
“…Homocysteine serves as the principal functional biomarker of OCM, and undergoes catabolism via remethylation and transsulfuration pathways, where folate acts as a methyl donor and vitamins B 6 and B 12 function as enzyme cofactors. Maternal Hcy concentration decreased from early to mid-gestation and increased from mid-to-late gestation in a normal pregnancy ( 36 ). Clinical studies have highlighted the potential impact of elevated maternal homocysteine during pregnancy on fetal cognitive decline ( 20 ) and Down’s syndrome ( 22 ).…”
Section: Discussionmentioning
confidence: 99%
“…Clinical studies have highlighted the potential impact of elevated maternal homocysteine during pregnancy on fetal cognitive decline ( 20 ) and Down’s syndrome ( 22 ). Insights from the Ottawa and Kingston birth cohort suggest an independent effect of early to mid-pregnancy elevated maternal Hcy on placenta-mediated pregnancy complications, even on children’s cardiovascular-metabolic diseases after delivery ( 13 , 36 , 37 ). In this study, 1.8% of mid-to-late pregnant women exhibited HHcy, with adequate blood folate and vitamin B 6 identified as protective factors against HHcy.…”
Section: Discussionmentioning
confidence: 99%